Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 141.61
0.79 %
$ 20.7 B
Market Cap
12.67
P/E
BIIB - CHANGE IN WORKING CAPITAL
Change in Working Capital BIIB - Biogen Inc.
-155 M
LAST VALUE
58.25%
2 YEAR CAGR
-12.21%
5 YEAR CAGR
10.76%
10 YEAR CAGR